Mediview Announces New Advisory Board Member (Sabeen)

MediView is pleased to announce the addition of Sabeen Shaikh as a new member to MediView’s Advisory Board.

Sabeen Shaikh is a healthcare executive with nearly 20 years of experience in the industry, who has held global commercial leadership roles between large multi-nationals and scaling start-ups. Sabeen’s expertise is focused in corporate strategy, commercial strategy, bringing new technologies to the developed and developing markets, change management and executive business leadership to build scalable businesses. She consults on a various range of health technologies that include hardware and software offerings across the Class 1 to Class 3 devices, as well as across a broad range of different clinical specialties.

Sabeen currently works across the breadth of the innovation ecosystem, including consulting for various multi-national corporates, venture capital and private equity funds, global start-ups and with a number of governments. Her work includes, but is not limited to: due diligence for investors on portfolio companies for investment, advisory and Board Directorship roles for investors and companies, building out global commercial strategies and international business operations for scaling companies, Executive-in-Residence roles such as Interim-CEO or Chief Commercial Officer for companies, and expert committee member in MedTech for government bodies.

Sabeen is passionate about healthcare access and the new market technology opportunities. She speaks on national and regional platforms about innovation trends, frugal and reverse innovation, and the needs to bridge the gaps within the innovation ecosystems between stakeholders. Sabeen is also passionate about the global innovation trends and where healthcare needs to be in the future.

Sabeen studied in the USA for her undergraduate degree and has continued further executive education with the INSEAD Business School.

Related posts:

Movers & Shakers: Adam Rakestraw on X-ray vision, building his own house and pivoting from law to medical tech MediView Recognized In The Medical Capital Innovation Competition MediView XR, Inc. Secures $15M Strategic Funding Round with Backing from Leading Collaborators across Clinical, Industry and Government Mediview Announces New Clinical Advisory Board Member (Jordan Tasse)